Pre-Market Top Gainer: GURN.SW Gurit at CHF15.06 on 24 Jan 2026: Momentum intact

Pre-Market Top Gainer: GURN.SW Gurit at CHF15.06 on 24 Jan 2026: Momentum intact

GURN.SW stock opens pre-market at CHF 15.06 on 24 Jan 2026 after a recent run that lifted the price from a 50-day average of CHF 11.96. Volume is light at 3,744 intraday shares but relative volume reads 4.37, signalling attention ahead of the next earnings date on 2 March 2026. Investors are watching technical momentum — RSI at 74.05 and ADX at 31.97 — while mixed fundamentals, a negative EPS of -20.54, and elevated debt ratios keep risk visible.

Pre-market price action and drivers for GURN.SW stock

GURN.SW stock trades at CHF 15.06, unchanged from the previous close but above the 200-day average CHF 13.62. The one-month gain is 43.33%, and the three-month gain is 49.63%, showing a sharp short-term rebound.

Market drivers include continued demand in wind and aerospace composites, short-covering after recent lows at CHF 10.02, and technical momentum. Watch the next public update and any SIX market notices for catalysts.

Earnings, financials and valuation metrics for GURN.SW stock

Latest company figures show EPS -20.54 and a negative P/E at -0.80, reflecting recent losses. Revenue per share is 81.88 and book value per share is 9.84, while cash per share is 2.93.

Key ratios highlight leverage: debt to equity is 2.06 and current ratio is 1.65. Price to book sits at 1.70 and EV/EBITDA is 31.34, indicating a mixed valuation compared with Basic Materials peers.

Technical setup and volume signals for GURN.SW stock

Momentum indicators look strong: RSI 74.05 (overbought), MACD histogram 0.13, and ADX 31.97 confirming a strong trend. Volume today is 3,744 versus average 9,993, but relative volume is 4.37, signalling outsized trade interest versus typical intraday flows.

Short-term support sits near the 50-day average CHF 11.96 and resistance near the year high CHF 19.44. Traders should watch for RSI cooling or a MACD cross for trend shifts.

Meyka AI grade, forecast and model view on GURN.SW stock

Meyka AI rates GURN.SW with a score out of 100: 58.24, Grade C+, Suggestion: HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics, forecasts, analyst consensus, and fundamental growth.

Meyka AI’s forecast model projects a monthly price of CHF 19.52, a quarterly price of CHF 24.94, and a yearly price of CHF 8.17. These model points reflect short-term momentum scenarios and longer-term downside risk. Forecasts are model-based projections and not guarantees. For more on the stock page visit Meyka stock page.

Sector context and risk factors for GURN.SW stock

Gurit operates in Chemicals – Specialty within Basic Materials. The sector average P/E is 20.40 and average debt-to-equity near 0.53, so Gurit’s leverage at 2.06 stands out as a risk. Sector trends show modest YTD gains, but commodity cycles and industrial demand will influence Gurit’s order book.

Operational risks include working capital pressure (days sales outstanding 83.64) and negative operating cash flow per share -0.35. Positive factors include diversified end markets and proprietary composite technology.

Analyst takeaways, price targets and trading considerations for GURN.SW stock

Company consensus data is limited; external ratings show mixed signals with DCF scores bullish but profitability metrics weak. Technical traders may target a short-term price target near the year high CHF 19.44 while risk managers note downside to the model yearly CHF 8.17.

Suggested tactical levels: stop-loss below CHF 11.96 (50-day average) and a speculative target zone CHF 18.00–CHF 19.50 for momentum trades. Monitor upcoming 2 March 2026 earnings.

Final Thoughts

GURN.SW stock is a top pre-market gainer on 24 Jan 2026, trading at CHF 15.06 as momentum indicators point higher while fundamentals remain mixed. Meyka AI’s forecast model projects a near-term monthly price of CHF 19.52, implying an upside of 29.64% versus the current price. The quarterly model point of CHF 24.94 implies a larger rally scenario, while the yearly projection of CHF 8.17 signals potential long-term downside under stress scenarios. Meyka AI rates GURN.SW with a score out of 100 at 58.24 (Grade C+, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Traders should balance technical strength — RSI 74.05, ADX 31.97 — against leverage (debt/equity 2.06) and negative EPS -20.54. For active traders the short-term reward-to-risk looks constructive; for longer-term investors the company must show operating cash flow recovery and improved margins before a clear BUY case forms. Remember, forecasts are model-based projections and not guarantees, and Meyka AI is an AI-powered market analysis platform providing data-driven insights, not investment advice.

FAQs

What drives the recent move in GURN.SW stock?

The move reflects short-term momentum, relative volume 4.37, and technical strength (RSI 74.05). Market interest in composites demand and positioning ahead of the 2 March 2026 earnings date also support the jump.

How does valuation look for GURN.SW stock?

Valuation is mixed: price to book 1.70 and price to sales 0.20 suggest value, but EV/EBITDA 31.34, negative EPS -20.54, and debt/equity 2.06 raise concerns about profitability and leverage.

What are Meyka AI’s price forecasts for GURN.SW stock?

Meyka AI’s forecast model projects a monthly price CHF 19.52, quarterly CHF 24.94, and yearly CHF 8.17. These represent scenario-based projections and are not guarantees.

Should investors buy GURN.SW stock before earnings?

Buying ahead of earnings carries risk. Technical momentum is positive, but fundamentals and cash flow remain weak. Consider position sizing and stops if trading the pre-earnings move.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *